Gerald McMahon
Algemeen Directeur bij STORM Therapeutics Ltd.
Profiel
Gerald McMahon currently works at STORM Therapeutics Ltd., as President, Chief Executive Officer & Director from 2022.
Dr. McMahon also formerly worked at Kolltan Pharmaceuticals, Inc., as President, Chief Executive Officer & Director, Harpoon Therapeutics, Inc., as President, Chief Executive Officer & Director from 2016 to 2021, Poniard Pharmaceuticals, Inc., as Non-Executive Chairman from 2010 to 2012, Oncotelic Therapeutics, Inc., as Independent Director from 2011 to 2016, Trellis Bioscience, Inc., as Director, Celldex Therapeutics, Inc., as Director from 2016 to 2018, MedImmune LLC, as Senior VP-Oncology Innovative Medicines Unit from 2010 to 2012, Sugen, Inc., as President from 1993 to 2004, Pharmacia Corp., as Senior Vice President-Research & Development, Massachusetts Institute of Technology, as Staff Investigator, and Bay City Capital LLC, as Venture Partner.
Dr. McMahon received his undergraduate degree from Rensselaer Polytechnic Institute and doctorate degree in 1980 from Rensselaer Polytechnic Institute.
Actieve functies van Gerald McMahon
Bedrijven | Functie | Begin |
---|---|---|
STORM Therapeutics Ltd.
STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Algemeen Directeur | 07-09-2022 |
Eerdere bekende functies van Gerald McMahon
Bedrijven | Functie | Einde |
---|---|---|
HARPOON THERAPEUTICS, INC. | Algemeen Directeur | 26-10-2021 |
CELLDEX THERAPEUTICS, INC. | Directeur/Bestuurslid | 05-12-2018 |
ONCOTELIC THERAPEUTICS, INC. | Directeur/Bestuurslid | 23-11-2016 |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01-05-2012 |
PONIARD PHARMACEUTICALS, INC. | Algemeen Directeur | 05-02-2010 |
Opleiding van Gerald McMahon
Rensselaer Polytechnic Institute | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
PONIARD PHARMACEUTICALS, INC. | Health Technology |
ONCOTELIC THERAPEUTICS, INC. | Health Technology |
HARPOON THERAPEUTICS, INC. | Health Technology |
CELLDEX THERAPEUTICS, INC. | Health Services |
Bedrijven in privébezit | 7 |
---|---|
Sugen, Inc.
Sugen, Inc. Pharmaceuticals: MajorHealth Technology Sugen, Inc. developed small molecule drugs and related pharmaceutical products. The company was founded on July 1, 1991 and was headquartered in New York, NY. | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Trellis Bioscience, Inc.
Trellis Bioscience, Inc. BiotechnologyHealth Technology Trellis Bioscience, Inc. is discovers and develops novel human antibody therapeutics. It provides the discovery and development of therapeutic antibodies from human B cells. The firm develops the CellSpot antibody discovery platform, which enables the identification of antibodies directly from human blood. The company was founded by Lawrence Kauvar and Stote Ellsworth in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Health Technology |
Bay City Capital LLC
Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Finance |
STORM Therapeutics Ltd.
STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Health Technology |